Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Change in Account Payables (2016 - 2025)

MedWellAI (MWAI) has disclosed Change in Account Payables for 11 consecutive years, with -$6473.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 61.04% to -$6473.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $7915.0, a 233.7% increase, with the full-year FY2025 number at $99594.0, up 191.65% from a year prior.
  • Change in Account Payables was -$6473.0 for Q4 2025 at MedWellAI, up from -$27655.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $503907.0 in Q2 2025 to a low of -$461864.0 in Q1 2025.
  • A 5-year average of $7147.4 and a median of $7684.0 in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: tumbled 1440.73% in 2021, then skyrocketed 680.67% in 2023.
  • MedWellAI's Change in Account Payables stood at -$54927.0 in 2021, then skyrocketed by 179.17% to $43487.0 in 2022, then crashed by 306.33% to -$89725.0 in 2023, then skyrocketed by 81.48% to -$16615.0 in 2024, then surged by 61.04% to -$6473.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Change in Account Payables are -$6473.0 (Q4 2025), -$27655.0 (Q3 2025), and $503907.0 (Q2 2025).